Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 5 for:    "Carcinoid Syndrome" | "Angiogenesis Modulating Agents"

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00227617
Recruitment Status : Unknown
Verified April 2015 by University of California, San Francisco.
Recruitment status was:  Active, not recruiting
First Posted : September 28, 2005
Last Update Posted : April 9, 2015
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Genentech, Inc.
Sanofi
Information provided by (Responsible Party):
University of California, San Francisco

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Actual Primary Completion Date : January 2012
Estimated Study Completion Date : June 2016
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 August 7, 2019
August 22, 2019